RNA Aptamers to Translational Components

被引:6
|
作者
Nakamura, Yoshikazu [1 ]
Endo, Kei [1 ]
Adachi, Hironori [1 ]
Ishiguro, Akira [1 ]
机构
[1] Univ Tokyo, Dept Basic Med Sci, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan
基金
日本科学技术振兴机构;
关键词
INITIATION-FACTOR; 4E; CAP-DEPENDENT TRANSLATION; FACTOR 4G EIF4G; BINDING PROTEIN EIF4E; RIBOSOMAL ENTRY SITE; MAMMARY-TUMOR VIRUS; DENDRITIC BC1 RNA; MESSENGER-RNA; EUKARYOTIC TRANSLATION; FACTOR; 4A;
D O I
10.1016/S1877-1173(09)90010-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Potential applications for functional RNAs are rapidly expanding, not only to address functions based on primary nucleotide sequences, but also by RNA aptamers, which can suppress the activity of any target molecule. Aptamers are short DNA or RNA folded molecules that can be selected in vitro on the basis of their high affinity for a target molecule. Here, we summarize RNA aptamers selected against human translation initiation factors, and their superior potentials to recognize and inhibit their target proteins. Importantly, the high affinity of RNA aptamers to proteins without RNA recognition motifs or intrinsic, strong affinity to RNA is achieved through the capture of the protein's global conformation. In other words, RNA has a high potential to form a vast set of tertiary structures, which we would like to refer to as 'RNA plasticity'. This provides us with a solid and promising basis to take steps to create novel RNA molecules of therapeutic potential with distinct structures, which should be equivalent or superior to antibodies.
引用
收藏
页码:369 / 395
页数:27
相关论文
共 50 条
  • [31] RNA Aptamers for Theranostics of Glioblastoma of Human Brain
    Alexey M. Kopylov
    Lika V. Fab
    Olga Antipova
    Ekaterina A. Savchenko
    Alexander V. Revishchin
    Viktoriya V. Parshina
    Svetlana V. Pavlova
    Igor I. Kireev
    Andrey V. Golovin
    Dmitry Y. Usachev
    Galina V. Pavlova
    [J]. Biochemistry (Moscow), 2021, 86 : 1012 - 1024
  • [32] RNA Aptamers: A Review of Recent Trends and Applications
    Kang, Kyung-Nam
    Lee, Yoon-Sik
    [J]. FUTURE TRENDS IN BIOTECHNOLOGY, 2013, 131 : 153 - 169
  • [33] Targeted delivery of RNA aptamers to diseased cells
    Roy, I.
    [J]. NEW BIOTECHNOLOGY, 2018, 44 : S24 - S24
  • [34] Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?
    Berzal-Herranz, Alfredo
    Romero-Lopez, Cristina
    [J]. PHARMACEUTICALS, 2020, 13 (08) : 1 - 10
  • [35] RNA Aptamers for Theranostics of Glioblastoma of Human Brain
    Kopylov, Alexey M.
    Fab, Lika, V
    Antipova, Olga
    Savchenko, Ekaterina A.
    Revishchin, Alexander, V
    Parshina, Viktoriya V.
    Pavlova, Svetlana, V
    Kireev, Igor I.
    Golovin, Andrey, V
    Usachev, Dmitry Y.
    Pavlova, Galina, V
    [J]. BIOCHEMISTRY-MOSCOW, 2021, 86 (08) : 1012 - 1024
  • [36] Application of aptamers and autofluorescent proteins for RNA visualization
    Schifferer, Martina
    Griesbeck, Oliver
    [J]. INTEGRATIVE BIOLOGY, 2009, 1 (8-9) : 499 - 505
  • [37] Gene therapy progress and prospects: RNA aptamers
    Que-Gewirth, N. S.
    Sullenger, B. A.
    [J]. GENE THERAPY, 2007, 14 (04) : 283 - 291
  • [38] STRUCTURAL INVESTIGATIONS OF RNA AND DNA APTAMERS IN SOLUTION
    DIECKMANN, T
    FUJIKAWA, E
    XHAO, XF
    SZOSTAK, J
    FEIGON, J
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 56 - 56
  • [39] RNA aptamers for an essential prebiotic molecule:: Adenine
    Meli, M
    Vergne, J
    Josse, T
    Décout, JL
    Maurel, MC
    [J]. EXO-/ASTRO-BIOLOGY, 2001, 496 : 367 - 370
  • [40] Composite RNA aptamers as functional mimics of proteins
    Xu, Daiying
    Shi, Hua
    [J]. NUCLEIC ACIDS RESEARCH, 2009, 37 (09)